These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35713235)

  • 1. Clinical and genomic characterisation of a fatal Puumala orthohantavirus case with low levels of neutralising antibodies.
    Tuiskunen Bäck A; Rasmuson J; Thunberg T; Rankin G; Wigren Byström J; Andersson C; Sjödin A; Forsell M; Ahlm C
    Infect Dis (Lond); 2022 Oct; 54(10):766-772. PubMed ID: 35713235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid capture-based next-generation sequencing of new and old world Orthohantavirus strains and wild-type Puumala isolates from humans and bank voles.
    Rosenbaum W; Bovinder Ylitalo E; Castel G; Sjödin A; Larsson P; Wigren Byström J; Forsell MNE; Ahlm C; Pettersson L; Tuiskunen Bäck A
    J Clin Virol; 2024 Jun; 172():105672. PubMed ID: 38574565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Grading the severity of disease in patients with Puumala or Dobrava virus infections from 1995 to 2000 in Croatia].
    Cebalo L; Dusek T; Kuzman I; Markotić A
    Acta Med Croatica; 2003; 57(5):355-9. PubMed ID: 15011460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity Biomarkers in Puumala Hantavirus Infection.
    Outinen TK; Mäkelä S; Pörsti I; Vaheri A; Mustonen J
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment.
    Pettersson L; Thunberg T; Rocklöv J; Klingström J; Evander M; Ahlm C
    Clin Microbiol Infect; 2014 Mar; 20(3):235-41. PubMed ID: 23742660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Lymphocyte Populations in Patients With Dobrava or Puumala orthohantavirus Infection.
    Resman Rus K; Kopitar AN; Korva M; Ihan A; Petrovec M; Avšič-Županc T
    Front Cell Infect Microbiol; 2020; 10():566149. PubMed ID: 33178625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and epidemiological characteristics of human Puumala and Dobrava-Belgrade hantavirus infections, Germany, 2001 to 2017.
    Faber M; Krüger DH; Auste B; Stark K; Hofmann J; Weiss S
    Euro Surveill; 2019 Aug; 24(32):. PubMed ID: 31411134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
    Mittler E; Wec AZ; Tynell J; Guardado-Calvo P; Wigren-Byström J; Polanco LC; O'Brien CM; Slough MM; Abelson DM; Serris A; Sakharkar M; Pehau-Arnaudet G; Bakken RR; Geoghegan JC; Jangra RK; Keller M; Zeitlin L; Vapalahti O; Ulrich RG; Bornholdt ZA; Ahlm C; Rey FA; Dye JM; Bradfute SB; Strandin T; Herbert AS; Forsell MNE; Walker LM; Chandran K
    Sci Transl Med; 2022 Mar; 14(636):eabl5399. PubMed ID: 35294259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the relationship between replication of the Hokkaido genotype of Puumala orthohantavirus and autophagy.
    Tamiya K; Kobayashi S; Yoshii K; Kariwa H
    Virus Res; 2022 Sep; 318():198830. PubMed ID: 35640779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puumala Orthohantavirus Reassortant Genome Variants Likely Emerging in the Watershed Forests.
    Kabwe E; Shamsutdinov AF; Suleimanova S; Martynova EV; Ismagilova RK; Shakirova VG; Savitskaya TA; Isaeva GS; Rizvanov AA; Khaiboullina SF; Morzunov SP; Davidyuk YN
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes.
    Klingström J; Smed-Sörensen A; Maleki KT; Solà-Riera C; Ahlm C; Björkström NK; Ljunggren HG
    J Intern Med; 2019 May; 285(5):510-523. PubMed ID: 30663801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells of the human respiratory tract support the replication of pathogenic Old World orthohantavirus Puumala.
    Hägele S; Nusshag C; Müller A; Baumann A; Zeier M; Krautkrämer E
    Virol J; 2021 Aug; 18(1):169. PubMed ID: 34404450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Detection of
    Reynes JM; Schaeffer L; Papadopoulos P; Ait-Ahmed M; Siby-Diakite D; Ripaux-Lefèvre M; Buivan TP; Lechat S; Vray M; Galempoix JM;
    J Clin Microbiol; 2023 Aug; 61(8):e0037223. PubMed ID: 37486218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing Antibody Titers in Hospitalized Patients with Acute Puumala Orthohantavirus Infection Do Not Associate with Disease Severity.
    Iheozor-Ejiofor R; Vapalahti K; Sironen T; Levanov L; Hepojoki J; Lundkvist Å; Mäkelä S; Vaheri A; Mustonen J; Plyusnin A; Strandin TM; Vapalahti O
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi- Species Validation and Evaluation in a Human Diagnostic Cohort.
    Hoornweg TE; Zutt I; de Vries A; Maas M; Hoogerwerf MN; Avšič-Županc T; Korva M; Reimerink JHJ; Reusken CBEM
    Front Cell Infect Microbiol; 2020; 10():580478. PubMed ID: 33415084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect effects of Puumala hantavirus on platelet function.
    Schrottmaier WC; Schmuckenschlager A; Thunberg T; Wigren-Byström J; Fors-Connolly AM; Assinger A; Ahlm C; Forsell MNE
    Thromb Res; 2024 Jan; 233():41-54. PubMed ID: 38006765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different cross-reactivity of human and rodent sera to Tula virus and Puumala virus.
    Tegshduuren E; Yoshimatsu K; Taruishi M; Endo R; Shimizu K; Koma T; Yasuda SP; Kariwa H; Arikawa J; Ishihara C
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e67-73. PubMed ID: 20116854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puumala Hantavirus Infections Show Extensive Variation in Clinical Outcome.
    Vaheri A; Smura T; Vauhkonen H; Hepojoki J; Sironen T; Strandin T; Tietäväinen J; Outinen T; Mäkelä S; Pörsti I; Mustonen J
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological study of hantavirus infection in the Samara Region of European Russia.
    Kariwa H; Tkachenko EA; Morozov VG; Seto T; Tanikawa Y; Kolominov SI; Belov SN; Nakamura I; Hashimoto N; Balakiev AE; Dzagurnova TK; Daud NH; Miyashita D; Medvedkina OA; Nakauchi M; Ishizuka M; Yoshii K; Yoshimatsu K; Arikawa J; Takashima I
    J Vet Med Sci; 2009 Dec; 71(12):1569-78. PubMed ID: 20046023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.